RE: AstraZeneca starts trial of COVID-19 antibody treatment28 Aug 2020 09:35
Qzqz, sorry for the rant, GSK though are an exceptional buy right now, especially with the split on the horizon . When it happens you will have shares in two of the biggest companies in their repective fields . GSK/Phizer healthcare will be really good with the products they already have on the market, gsk majority holder. And the vaccine side is going to be even bigger than it is now. Which is already quite big. My average is about 17 but I’m more than happy. As I get over £ 1000 per annum Divs and think the future is solid. :-).